Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Raw Materials of $1.1 million for Q4 2025, up 8.17% year-over-year from $1.0 million in Q4 2024, and up 8.17% quarter-over-quarter from $1.0 million in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Raw Materials for 3 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Raw Materials rose 8.17% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 8.17% YoY), while the FY2025 annual figure was $1.1 million, up 11.38% from the prior year.
- Raw Materials rose to $1.1 million in Q4 2025 per ZYBT's latest filing, from $1.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $1.4 million in Q4 2023 and bottomed at $1.0 million in Q4 2024.
- Historically, Raw Materials has averaged $1.2 million across 3 years, with a median of $1.1 million in 2025.
- Annual changes were most pronounced in 2024 — Raw Materials decreased 24.54% — and 2025, when it increased 8.17%.
- Zhengye Biotechnology Holding's Raw Materials stood at $1.4 million in 2023, then fell by 24.54% to $1.0 million in 2024, then grew by 8.17% to $1.1 million in 2025.
- Business Quant data shows ZYBT's Raw Materials at $1.1 million in Q4 2025, $1.0 million in Q4 2024, and $1.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 1.37 Mn |